Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Bromocriptine
Bromocriptine Parlodel Parlodel Parlodel Parlodel, ergot alkaloids

Action
Bromocriptine ( broe-moe-KRIP-teen) belongs to the group of medicines known as ergot alkaloids. Bromocriptine blocks release of a hormone called prolactin from the pituitary gland. Prolactin affects the menstrual cycle and milk production. Bromocriptine is also used to treat acromegaly (overproduction of growth hormone) and pituitary prolactinomas (tumors of the pituitary gland). Bromocriptine is also used to treat some people who have Parkinson's disease and works by stimulating certain parts of the brain and nervous system that are involved in this disease.

Status

Trial(s)
  = Ongoing
  = Completed

Trial of bromocriptine efficacy in nonfluent aphasia after stroke

Web Links and Publications

UID: 205

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2010 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, March 12, 2010